BioCatalyst

Mezigdomide, Carfilzomib, Dexamethasone — catalyst calendar

1 verified catalyst event(s) referencing Mezigdomide, Carfilzomib, Dexamethasone, each linked to its official source. Verified as of 2026-09-25.

Upcoming

DateEventCompanyDrugOfficial source & verification
2026-09-28
in 3d
ESTIMATED
 READOUT
A Study to Evaluate Mezigdomide in Combination With Carfilzomib and Dexamethason
Phase 3 · Relapsed or Refractory Multiple Myeloma
 BMY BRISTOL MYERS SQUIBB CO Mezigdomide, Carfilzomib, Dexamethasone ClinicalTrials.gov ↗
✓ Source-checked 2026-09-25
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.